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ABSTRACT 
Oxidative stress induced by a high ammonia concen- 
tration could modify protein expression in the brain. 
This study was undertaken in order to investigate the 
impact of hyperammonemia, caused by thioacetmide 
(TAA) in rats, on brain cortex protein expression us- 
ing 2D-DIGE, and analyzing its role in the patho- 
genesis of HE. Hyperammonemia was induced with 
TAA. Ammonia and active oxidants were measured 
by L-glutamate dehydrogenase and dichlorodihydro- 
fluorescein diacetate methods, respectively. Lipid per- 
oxidation and protein oxidation biomarkers were also 
studied. Differential protein expression in the cortex 
of TAA- and control-rats was studied by 2D-DIGE. 
Image analysis was performed using the DeCyder™ 
Software. Ammonia concentration in plasma and 
brain tissue was higher in TAA-rats compared to 
control-rats, 3.12 and 2.43 fold higher, respectively. 
Active oxidants production in TAA-rats was increased 
by 2.7 fold compared to control-rats. Measurements 
of MDA, HNE and carbonyl groups, biomarkers of 
lipid peroxidation and protein oxidation respectively, 
were found to be statistically significantly increased 
in TAA-rats compared to control-rats (3.16-, 2.44- 
and 1.95-fold, respectively), reflecting the presence of 
oxidative stress in the brain of TAA-rats. 2D-DIGE 
analysis of brain cortex protein allowed the detection 
of 2896 spots, however, image analysis showed no 
statistically significant differential protein expression 
between the proteins expressed in TAA- and con- 
trol-rats. No statistical significant differential protein 
expression in the cortex of TAA-rats was observed, 
although oxidative stress biomarkers for lipid and 
proteins were higher in the brain of TAA-rats than in 
control-rats. These results support the idea that oxi- 
dative post-translational modifications are implicated 
in HE physiopathology. 
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1. INTRODUCTION 
Hepatic encephalopathy (HE) is the major neurologic 
disorder occurring in patients with severe liver disease 
which presents in chronic and acute forms. Chronic HE 
is a neuropsychiatric disorder which commonly occurs in 
the setting of alcoholic cirrhosis and is often associated 
with changes in personality, altered mood, decline in 
intellectual capacity and abnormal muscle tone. Acute 
HE (acute liver failure) has a high mortality rate (80% - 
90%) due to the development of brain edema and in- 
creased intracranial pressure, and often presents with the 
abrupt onset of delirium, seizures and coma [1]. Al- 
though the pathophysiology of HE remains unclear, it is 
well established that ammonia plays a major role [2,3]. 
Ammonia accumulates in the brain in both acute and 
chronic liver failure, leading to a series of metabolic, 
energetic and signal transduction-related alterations [4]. 
However, it appears that other factors may also contrib- 
ute. In particular, microglial activation and brain in- 
flammation correlate with the progression of encephalo- 
pathy and the onset of brain edema in rats with acute 
liver failure [5]. Moreover, increased expression of the 
endothelial and inducible isoforms of nitric oxide syn- 
thase as well as heme oxygenase-1 [6] and direct oxida- 
tive biomarkers [7,8] have been reported in animal mod- 
els, suggesting that oxidative/nitrosative stress also plays 
a significant role in the pathogenesis of brain complica- 
tions observed in liver failure, and particularly in HE. 
*This work was supported by a grant (Accion integrada: DE2009-0098) 
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cated in the development of HE, but they are not able to 
give any precise information about the mechanisms and 
proteins/enzymes involved in the physiopathology of HE. 
Therefore, the aim of the present work was to study the 
effect of oxidative stress, induced by high ammonia con- 
centration, on rat brain proteins, using an animal model 
of HE. As a model of chronic HE, TAA-rats are often 
used because they allow studying longer exposition to 
high ammonia concentrations than the PCS-rat model [9]. 
In an attempt to gain knowledge on the pathogenesis of 
chronic HE, differential proteins expression was studied 
using a two dimensional differential in gel electrophore- 
sis (2D-DIGE) approach, which allowed its identification 
and to study its relation with HE. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Chemicals, proteases, and antibodies used in these stud- 
ies were mainly purchased from Sigma-Aldrich (Madrid, 
Spain). Electrophoresis and DIGE materials were pur- 
chased from GE Healthcare (Barcelona, Spain). Super- 
Signal West Pico Chemiluminiscent Substrate was pur- 
chased from Thermo Scientific Inc. (Rockford, USA). 
2.2. Animals 
Male Wistar rats (n = 20) weighing 230 - 260 g at the 
beginning of the experiments, were used in the present 
study. Animals were supplied by the Centre of Produc- 
tion and Experimental animal of Espartinas, University 
of Seville, Spain. The animals were housed four per cage, 
and maintained at constant room temperature (22˚C ± 
2˚C), with artificial light-dark cycle of 12 h and a relative 
humidity of 65% - 70%, and free access to food and wa- 
ter during 2 weeks for acclimation. All animal proce- 
dures were performed with approval from the Sevilla 
University Animal Ethics Committees, under the guide- 
lines of the directive 86/609/CEE of the European Com- 
munity. 
2.3. Animal Model of HE (Thioacetamide  
Treatment) 
After the 2 weeks of acclimation, the animals were di- 
vided into two groups, and two animals per cage: control 
group (n = 10) and thioacetamide (TAA) treated group 
(TAA-rats, n = 10). The control-rats received food and 
normal water and served as a control for 16 weeks. The 
TAA-rats received food and continuous administration of 
0.03% TAA (Sigma, Madrid, Spain) in the drinking wa- 
ter as an initial concentration that was subsequently modi- 
fied according to weight changes in response to TAA 
during the induction of cirrhosis. The treatment was 
maintained during 12 weeks [10]. At the 12th week the  
TAA-rats group had 8 animals (n = 8) and the control-rat 
group had 10 animals (n = 10). Animals were weighed 
weekly. Animals were killed by an overdose of pento- 
barbital and brains rapidly removed. Different brain loci 
(cortex, cerebellum, hippocampus) were dissected, fro- 
zen with liquid N2, and stored at –80˚C until use. In this 
study the cortex was used. 
2.4. Sample Preparation for Analytical  
Procedures 
Brain samples (cortex) (100 mg) were homogenized in 1 
ml homogenization buffer (10 mM Hepes, 137 mM NaCl, 
4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4, 0.5 
μg/ml leupeptin, 0.7 μg/ml pepstatin, 0.5 μg/ml type II S 
soybean trypsin inhibitor, 40 μg/ml PMSF), using a man- 
ual glass homogenizer (~50 passes). Homogenates were 
vortexed and sonicated for 10 s at 20% power in a soni- 
cation bath (Braun, Berlin, Germany), and centrifuge at 
2500 × g in a microfuge (Mikro 200R, Hettich, Tübingen, 
Germany) to remove intact cells and nuclei. Protein con- 
centrations were determined according to the Bradford 
method [11]. 
2.5. Measurement of Ammonia Concentration 
Ammonia concentrations were measured in arterial plasma 
and brain tissue using the L-glutamate dehydrogenase 
method [12]. Plasma concentrations of ammonia were 
measured before the TAA-treatment and at the time of 
killing. Ammonia concentration was calculated and ex- 
pressed as μmol/l. Brain tissue was homogenized as de- 
scribed above, and deproteinized in 5 volumes of ice- 
cold trichloroacetic acid (TCA) (100 g/l), and kept on ice 
for 15 min. After centrifugation at 12,000 × g for 10 min 
at 4˚C, the supernatant was collected, neutralized with 2 
M KHCO3 and centrifuged at 12,000 × g for 10 min at 
4˚C. The neutralized supernatant was used to measure 
ammonia by the glutamate dehydrogenase method as 
described above. 
2.6. Measurement of Active Oxidants Production 
Brain active oxidants production was measured in brain 
homogenates obtained as described above by the Thor- 
burne and Juurlink method [13] using 5-(and-6)-carboxy- 
20,70-dichlorodihydrofluorescein diacetate (DCFDA), with 
minor modifications [14]. 
2.7. Measurement of Low Molecular  
Dialdehydes 
Malondialdehyde (MDA) was determined by HPLC ac- 
cording to Mateos et al. [15] as described in [8]. 4-Hy- 
droxy-2-noneal (HNE) was determined according to stan- 
dard immunodetection procedures [16] as described in [8]. 
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2.8. Measurement of Carbonyl Groups 
The total protein carbonyl levels in homogenates from 
brain tissue (cortex) obtained in homogenization buffer, 
as described above, of TAA- and control-rats were as- 
sayed following the Evans method [17] as described in 
[8]. 
2.9. Sample Preparation for Electrophoretic 
Separations 
Cortex samples (in control or TAA-treated rats) were 
made powder with liquid N2 and kept at –80˚C. Ap- 
proximately 10 mg of powder were mixed with 100 µl of 
lysis buffer (30 mM Tris-Cl pH 8.5, 2 M Thiourea, 7 M 
Urea, 4% (w/v) Chap). The homogenate were left on ice 
10 minutes and sonicated 5 min. The homogenates were 
centrifuged in QIAshredder (Qiagen, Hilden, Germany) 
for eliminate the DNA and then centrifuged 15 min at 
18,000 g at 4˚C in a microfuge (Mikro 200 R, Hettich, 
Tübingen, Germany). The supernatant was taken and 
protein content was determined according to the method 
of Bradford [11]. 
2.10. Conventional 2D-Electrophoresis 
Protein samples (150 µg) were loaded onto IPG strips 
(pH 4 - 7, 13 cm) previously hydrated over-night with 
rehydration buffer (2 M Thiourea, 7 M Urea, 4% (w/v) 
Chaps, 0.2% IPG Buffer pH 3 - 10, 0.2% (w/v). The first 
dimension was performed using IPGphor 3 IEF system 
(GE Healthcare, Buckinghamshire, UK) at 20˚C. The 
conditions for the IEF were performed according to the 
manufacturer’s instructions (300 V during 3 hours, gra- 
dient to 1000 V during 3 h, gradient to 8000 V during 6 h, 
8000 V during 6 h). The focused strips were equilibrated 
in equilibration buffer (50 mM Tris-Cl, 6 M Urea, 30% 
(v/v) glycerol, 2% (w/v) SDS) with 1% (w/v) dithio- 
threitol (DTT) for 15 min and transferred to 2.5% (w/v) 
iodoacetamide for 15 min. The SDS-polyacrilamide gel 
electrophoresis (SDS-PAGE) was run on 12% T and 
2.7% C, 20˚C, 450 V, 10 W, 15 mA/gel 10 min, 25 
mA/gel 2 h using a Criterion Cell unit (Bio-Rad Labora- 
tories Inc., Munich, Germany). Two gels were stained 
with SYPRO-Ruby protein gel staining to visualize total 
proteins and for protein identification. 
2.11. Differential in Gel Electrophoresis 
2.11.1. Sample Preparation and Protein Labeling with 
Cydye 
Proteins samples (100 mg cortex) of control and TAA- 
treated rats were treated with 2-D Clean-Up Kit (GE 
Healthcare) following the manufacturer’s instructions. 
The protein pellet was resuspended in lysis buffer (30 
mM Tris, 7 M urea, 2 M thiourea, and 4% (w/v) CHAPS  
pH 8) and adjusted to pH 8. Protein concentration was 
determined using the Bradford method. Prior to labeling 
the proteins with saturation dye, the amounts of Tris (2- 
carboxyethyl) phosphine hydrochloride (TCEP; Invitro- 
gen, USA) and dye were optimized according to the 
manufacturer’s protocol. 
Traditional three-dye system was employed to reduce 
variability associated with the multiple samples being 
compared [18]. Control and TAA-treated rat samples 
were labeled with N-hydroxy succinimidyl ester deriva- 
tives of the cyanine dyes Cy2, Cy3, and Cy5 following a 
standard protocol [19]. 
2.11.2. 2-D Gel Electrophoresis 
Immobilised 24 cm linear pH gradient (IPG) strips, pH 
3-11NL, were rehydrated in rehydration buffer (7 M 
Urea, 2 M Thiourea, 4% CHAPS, 0.5% IPG Buffer, 50 
mM DTT) overnight, according to the standard guide- 
lines. Iso-Electric-Focusing (IEF) was performed using 
an IPGphorTM 3 apparatus (GE Healthcare) for a total of 
40 kV/hour at 20˚C. Equilibrated IPG strips were trans- 
ferred onto 12.5% uniform polyacrylamide gels poured 
between low fluorescence glass plates. Strips were over- 
laid with 0.5% w/v low-melting-point agarose in running 
buffer containing bromphenol blue. Gels were run using 
the Ettan Dalt 12 device (GE Healthcare) at 2.5 W/gel 
for 30 minutes then 100 W in total at 10˚C until the dye 
front had run off the bottom of the gels. 
2.11.3. Image Acquisition and Statistical Analysis 
After second-dimension SDS-PAGE, gels were scanned 
using the Typhoon 9400 variable mode imager (GE 
Healthcare). Cy2 protein maps were scanned using a 
488-nm laser with a 530-nm emission filter; Cy3 was 
scanned using a 532-nm laser with a 605-nm emission 
filter; Cy5 was scanned using a 635-nm laser with a 
695-nm emission filter. Gels were scanned at 100 μm 
resolution. Image analysis was performed using the De- 
Cyder™ Software version 7.0 (GE Healthcare). Gel-to- 
gel matching of the standard protein maps from each gel, 
followed by statistical analysis of differential protein 
abundance between samples, was determined using the 
biological variation analysis module (BVA) of DeCy- 
der™. Analysis of variance (ANOVA) was applied to 
matched spots and the data were filtered to retain protein 
spots with p ≤ 0.05 determined by 1-way ANOVA and a 
fold-change of ≥1.2. Using the EDA Version 1.0 (ex- 
tended data analysis) module within the DeCyder soft- 
ware (GE Healthcare), data analysis was performed us- 
ing principal components analysis (PCA) on proteins of 
interest [20]. 
2.12. Statistical Analysis 
Results are expressed as mean ± SEM. Statistical analy- 
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sis was carried out using Student’s t test. A value of p < 
0.05 was considered significant. 
3. RESULTS 
In this work we have studied the effect of oxidative 
stress induced by hyperammonemia in an animal model 
(TAA-rats) of HE. Our aim has been the analysis of pro- 
tein expression in the brain of TAA-rats and control-rats, 
and the correlation between these alterations and the 
physiopathology of HE. 
 OPEN ACCESS 
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First of all, we have confirmed that the animal model 
used, TAA-rats, was a suitable model to study HE-asso- 
ciated hyperammonemia. Rats treated with TAA showed 
symptoms of brain injury such as lethargy, lack of spon- 
taneous movement, loss of righting reflex, lack of re- 
sponse to pain; and as shown in Table 1, the level of 
ammonia in plasma (303.98 ± 13.56 μmol/l versus 97.50 
± 9.23 μmol/l) and in brain cortex (8.39 ± 1.07 μmol/g 
tissue versus 3.44 ± 0.56 μmol/g tissue) were higher in 
TAA-rats compared with control-rats. 
3.1. Oxidative Stress Biomarkers 
Once it was established that TAA-rats were hyperam- 
monemic, and that its behavior was related with some of 
the hallmarks of HE and taken into account that oxida- 
tive stress has been implicated as possible cause of HE 
[7-9,14], we tested the hypothesis that high ammonia 
concentration could promotes oxidative stress in the 
brain of TAA-rats. For this purpose the production of 
active oxidants (see Figure 1) and biomarkers of lipid 
and protein oxidations (see Table 1) have been quanti- 
fied. 
Measurements of global active oxidants production 
were carried out in a heterogeneous mixture of neurons, 
glial and microglial cells from TAA- and sham-rat brain 
using DCFDA as a probe. As Figure 1 shows, active 
oxidants production in TAA-rats was 2.47 times higher 
than that of the control-rats (247% ± 16% versus 100%, 
respectively). Since DCFDA method mainly measured 
reactive oxygen species (ROS) we also investigated the 
production of reactive nitrogen species using nitric oxide 
(NO) as an appropriate marker of reactive nitric species 
(RNS). The production of NO was significantly higher in 
TAA-rats than in control-rats (21.80 ± 1.57 μmol/mg 
protein versus 14.76 ± 1.26 μmol/mg protein, respec- 
tively, p < 0.01) (Figure 2). 
Measurement of low molecular dialdehydes (MDA 
and HNE) and carbonyl groups, biomarkers of lipid per- 
oxidation and protein oxidation, respectively, were car- 
ried out by standardized methods as described in Materi- 
als and Methods. Results are shown in Table 1. The 
oxidation of lipids has been analyzed using two different 
methods: malondialdehyde (MDA) and 4-hydroxy-2- 
nonenal (HNE). In both cases, we found higher levels in 
TAA-rats than in control-rats (0.062 ± 0.006 μmol 
MDA/mg protein versus 0.021 ± 0.004 μmol MDA/mg 
protein, p < 0.01; and 0.018 ± 0.003 μmol HNE/mg pro- 
tein versus 0.008 ± 0.002 μmol HNE/mg protein, p < 
0.01, respectively). 
 
Table 1. Ammonia concentration in plasma and cortex. Lipid 
peroxidation and protein oxidation in the cortex of control- and 
TAA-rats. 
 Control-rats TAA-rats 
Ammonia: 
Plasma (µmol/l) 
Cortex (µmol/g tissue) 
 
97.50 ± 9.23 
3.44 ± 0.56 
 
303.98 ± 13.56
8.39 ± 1.07 
 
<0.01
<0.01
Lipid peroxidation: 
MDA (µmol/mg protein)
HNE (µmol/mg protein) 
 
0.026 ± 0.004 
0.016 ± 0.002 
 
0.082 ± 0.010
0.039 ± 0.004
 
<0.01
<0.01
Protein oxidation: 
C = O (nmol/mg protein)
 
2.72 ± 0.24 
 
5.32 ± 0.47 
 
<0.01
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Figure 1. Active oxidants production in control- and TAA-rats. 
P. Carbonero-Aguilar et al. / Advances in Bioscience and Biotechnology 3 (2012) 1116-1123 1120 
0
5
10
15
20
25
control‐rats TAA‐rats
N
O
 pr
od
uc
tio
n (
um
ol
/m
g p
ro
te
in
)
 
Figure 2. NO production in control and TAA-rats. 
 
Protein oxidation has been studied by quantification of 
carbonyl groups, by 2,4-dinitrophenylhidrazine (DNPH) 
method, observing a higher level of protein oxidation in 
TAA-rats compared to sham-rats (5.30 ± 0.57 nmol/mg 
protein versus 2.72 ± 0.24 nmol/mg protein, p < 0.01, 
respectively). 
These results show that hyperammonemia promotes 
oxidative stress in the brain of TAA-rats, but they do not 
reveal the mechanisms and proteins involved in the 
physiopathology of HE. 
3.2. 2D-DIGE Analysis of Hyperammonemic Rat 
Brain Cortex Proteins 
In order to identify proteins involved in the physiopa- 
thology of HE, we have studied differential protein ex- 
pression in brain cortex from TAA- and control-rats. 
Differential protein expression pattern has been analyzed 
by 2D-DIGE technique using minimal labeling with 
three fluorophores (Cy2, Cy3 and Cy5). Contrary to 
conventional protein staining such as Coomassie brilliant 
blue (CBB) or silver staining, fluorescent tagging of the 
entire brain cortex proteins drastically increases the num- 
ber of detectable protein spots in standard 2-DE. A pre- 
vious proteomic study of brain rat brain cortex proteins 
using CBB G-250 resulted in the detection of 636 indi- 
vidual 2-D spots (results not shown). The fluorescent 
DIGE analysis of brain cortex protein from TAA- and 
control-rats described here resulted in the visualization of 
2896 ± 18 spots (Figure 3). Hence, the DIGE-based 
proteomic profiling study of brain cortex rat proteins is 
approximately 4.5-fold more sensitive as compared to 
conventional protein labelling techniques. In addition, 
gel-to-gel variations in the 2-D protein distribution pat- 
tern are greatly reduced due to the simultaneous analysis 
of two different proteomes and a pooled standard on the 
same slab gel [21-23]. Thus, around 3000 differentially 
labelled brain cortex proteins can be analyzed per gel 
using 2D-DIGE technology, which is far superior to 
conventional nonfluorescent methods. In order to prevent 
the introduction of potential artifacts due to subcellular 
fractionation, this study employed total brain cortex ex- 
tracts as starting material for our comparative proteomic 
profiling study. Consequently, the brain cortex proteins 
analyzed here represents major soluble proteins and 
therefore does not take into account potential changes in 
integral receptors and other non-soluble components. 
Figure 3 illustrates the representative protein spot pat- 
tern obtained for a 2D-DIGE experiment, showing the 
spots obtained for the control-rats cortex proteins (Cy3 
excited, image A) and the TAA-rats cortex proteins (Cy5 
excited, image B), respectively. As shown in the super- 
position of protein spot pattern obtained by labeling with 
Cy3 and Cy5 (image C). The analysis of these results by 
the DeCyder™ Software, reveals that no statistical dif- 
ferences between protein expressions in the cortex of 
TAA- and control-rats were observed. 
4. DISCUSSION 
To verify that after 12 weeks TAA-treated rats (n = 8) 
were hyperammonemic, ammonia concentration in plasma 
and brain of control- and TAA-rats was assessed; ob- 
taining the following results: 96.6 ± 12.3 μmoles/l and 
356.6 ± 32.3 μmoles/l, p < 0.01, in plasma and 0.36 ± 
0.05 μmoles/g tissue and 0.97 ± 0.13 μmoles/g tissue, p < 
0.01, in the brain, respectively. These results show that 
ammonia levels in plasma and total brain tissue were 
higher in TAA-rats compared to control-rats, 3.12- and 
2.43-fold higher, respectively. 
The presence of oxidative stress in the brain of 12 
weeks-old TAA-rats was confirmed by measurement of 
global active oxidants production, in a heterogeneous 
mixture of neurons, glial and microglial cells from TAA- 
and control-rat brain. Active oxidants production was 
measured using DCFDA as a probe. Active oxidants  
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Figure 3. 2-D gel images of rat cortex labeled with minimal CyDye DIGE fluorophores. Control-rats sample labeled with Cy3, (a); 
TTA treated-rats sample labeled with Cy5, (b); Superposition of images A and B, (c). 
 
production in TAA-rats was 2.7-fold higher than con-
trol-rats (Figure 1). The measurement of low molecular 
dialdehydes (MDA and HNE) and carbonyl groups, bio- 
marker of lipid peroxidation and protein oxidation, re- 
spectively, were found to be significantly increased in 
TAA-rats compared with control-rats (Table 1). This 
result reflects the presence and action of oxidative stress 
in the brain of 12 week-old TAA-rats, where lower en- 
zymatic antioxidant defense has been described too [24, 
25]. 
These results agree with other studies that show that 
high ammonia concentration exposure induces oxidative 
stress in rat astrocyte cultures and mouse brain slices in 
vitro [14,26,27], and in vivo in the rat brain [24]. 
Metabolic, energetic and signal transduction-related 
alterations observed in HE and hyperammonemic rats [4] 
has been related with altered movements and psycho- 
intellectual activities. These alterations might be ex- 
plained in part by differential expression of proteins and 
enzymes in the cortex of hyperammonemic rats [28-30], 
a brain area related with psychomotoric disturbances. 
Therefore, we study protein expression in the cortex of 
TAA-rats, an animal model of chronic HE, and sham-rats 
by a proteomic approach based on 2D-differential in gel 
electrophoresis (2D-DIGE). 
2D-electrophoresis is an important proteomic tool, 
where thousands of proteins spots can be visualized, re- 
sulting in a global view of the state of a proteome [31], 
and comparing the 2D spot patterns from different sam- 
ples (control- and TAA-rats cortex, for example), changes 
in individual proteins abundance can be detected and 
quantified; allowing the identification of protein markers 
that are characteristic for a specific physiological or 
pathological state of a cell or a tissue [32]. However, a 
limitation on comparative 2-D analysis is the high degree 
of gel-to-gel variation in spot patterns that makes it dif- 
ficult to distinguish any true biological variation from 
experimental variation [33]. A method that minimized 
these drawbacks is differential in gel electrophoresis 
(DIGE), were samples are labeled prior to electrophore- 
sis with spectrally resolvable dyes CyTM2, Cy3 and Cy5. 
Samples are then mixed prior to EIF and resolved on the 
same gel [21]. The fluorophores are structurally similar 
and undergo nucleophilic substitution with the ε-amino 
group of lysine residues forming an amide. The fluores- 
cent dyes have very similar molecular masses and are 
positively charged to mach the charge that is replaced on 
the lysine residue. This charge/mass matching ensures 
that all the samples essentially comigrate to the same 
point during electrophoresis. This ensures that, when the 
dye:protein ratio is low, protein molecules are only la- 
belled with a single dye molecule [22], refining greatly 
the detection of changes at the protein level between 
samples. 
Variation in spot intensity due to experimental factors, 
such as protein loss during sample entry into the strips, 
will be the same for each sample within a single DIGE 
gel. Therefore the relative amounts of a protein between 
samples in a gel will be unchanged. With conventional 
“one sample per gel” 2D techniques, samples to be com- 
pared are separated independently in different gels, and 
consequently, spot migration and intensity will be differ 
for each gel and sample in an experiment adding to the 
overall experimental variation.  
The analysis of the spots (Figure 3) showed no statis- 
tically significant differences in expression among the 
2896 resolved spots by DIGE method in the cortex of 
TAA-treated rats and control-rats. Although these results 
clearly indicate that no statistically significant differ- 
ences (p < 0.05) were observed between TAA-treated 
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rats and sham-rats, it should be stated that systematic 
differences for 14 spots were observed by DIGE study. 
Although these slightly differences could not be consid- 
ered as the main causes of HE, its role should also not be 
excluded. 
These results support the idea that oxidative post- 
translational modifications are implicated in HE physiopa- 
thology, and have leaded us to consider the hypothesis 
that the cause of HE lies in post-translational modifica- 
tions rather than in differential expression of proteins. 
We are currently working on this hypothesis. 
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